Continuous Renal Replacement Therapy Market Research Elaborate Analysis with Growth Forecast To 2026
Renal replacement therapy is used to replace the kidneys' typical blood-filtering role. Treatment of severe acute kidney injuries and end-stage renal disorders depend heavily on it. Peritoneal dialysis, intermittent hemodialysis, and continuous renal replacement treatment are the three different types of renal replacement therapy.
Increased prevalence of chronic kidney disease is expected to spur Continuous Renal Replacement Therapy Market. The prevalence of chronic kidney disease, which is a major risk factor for diabetes, hypertension, cardiovascular disease, and the inflammatory kidney disease glomerulonephritis, is one of the main drivers driving the expansion of the market for continuous renal replacement therapy.
Around 200 million people were diagnosed with chronic kidney disease in 2014, according to the National Center for Biotechnology Information (NCBI). If neglected, this condition can culminate in end-stage renal disease, renal failure, or full loss of kidney function. require ongoing renal replacement therapy as a result.
The Continuous Renal Replacement Therapy Market is anticipated to be dominated by North America due to the increased prevalence of chronic kidney disease.
The increase in acute kidney injury cases and other technological developments in the paediatric field, such as the Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIUM) for the treatment of acute kidney injury in small infants, are other factors propelling the growth of the Continuous Renal Replacement Therapy Market. However, the reasons that are limiting the growth of the market for continuous real replacement treatment include reimbursement, procedure expenses, the high complexity of continuous renal replacement therapy, and a lack of qualified nurses.
Additionally, a cutting-edge medical device known as a wearable artificial kidney that was introduced in the United States in 2015 is intended to give continuous renal replacement throughout the day, making it practical and affordable for patients. Due to the high unmet medical needs associated with target diseases like diabetes and hypertension as well as the ongoing rise in investments aimed at improving healthcare infrastructure, Asia Pacific is also anticipated to become the most lucrative market for continuous renal replacement therapy over the forecast period.
Comments
Post a Comment